title: High-dose ara-C and VP-16 before conditioning for bone marrow transplantation in patients with high-risk leukemia.
authors.forename: B
authors.initials: B
authors.lastname: Häfliger
authors.forename: A
authors.initials: A
authors.lastname: Gratwohl
authors.forename: A
authors.initials: A
authors.lastname: Tichelli
authors.forename: A
authors.initials: A
authors.lastname: Würsch
authors.forename: B
authors.initials: B
authors.lastname: Speck
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000628:therapy*; D008297:Male
chemical_list: D003561:Cytarabine; D005047:Etoposide